The fact that China hasn’t approved any commercial GMO planting since 2009 reflects public fears.
David TalbotFollow @twitterapi
I’m MIT Technology Review's chief correspondent, keeping an eye most often on the world of information and communication technologies—and asking my kids when I don’t understand what’s going on. Recent projects have taken me to Kenya to write about mobile-phone-based health initiatives, and Germany to explore how they’ll ramp up renewable power while closing down nuclear plants. My 2008 feature on the Obama campaign’s social-networking operation was selected for The Best Technology Writing 2009.
David Talbot's Stories
Researchers have created wheat that is resistant to a common disease, using advanced gene editing methods.
Software could prevent sensitive medical data from being inadvertently shared as health records get passed around.
The Supreme Court’s decision was tailored narrowly, but it may provide openings for lawyers to argue that other forms of mass Internet streaming violate copyright.
A new wearable sensor listens for sounds that betray your activity and mood.
Gabriel Kreiman’s single-neuron measurements of unconscious decision-making may not topple Descartes, but they could someday point to ways we can learn to control ourselves.
Indoor location technologies are a boon to retailers but may not be so welcome to consumers.
A technique for using MRI to detect molecules released during brain injury could lead to quicker emergency diagnoses.
Reported plans to launch 180 satellites could provide significant competition in the developing world and rural areas.
A new haptic sculpting tool heralds a coming boom in 3-D modeling and manipulation.